XML 90 R41.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Information (Tables)
 12 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
Reconciliation of Segment Information to Total Consolidated Information
Presented in the table below is segment information for the periods identified and a reconciliation of segment information to total consolidated information.
(In millions)
North America
 
Europe
 
Rest of World
 
Corporate / Other
 
Consolidated
Year Ended December 31, 2018
 
 
 
 
 
 
 
 
 
Net sales
$
4,095.6

 
$
4,157.3

 
$
3,015.8

 
$
—

 
$
11,268.7

Other revenue
112.4

 
27.1

 
25.7

 
—

 
165.2

Intersegment revenue
85.2

 
107.8

 
343.9

 
(536.9
)
 
—

Total
$
4,293.2

 
$
4,292.2

 
$
3,385.4

 
$
(536.9
)
 
$
11,433.9

 
 
 
 
 
 
 
 
 
 
Segment profitability
$
1,838.4

 
$
1,089.5

 
$
692.0

 
$
—

 
$
3,619.9

 
 
 
 
 
 
 
 
 
 
Intangible asset amortization expense
 
 
 
 
 
 
 
 
(1,606.4
)
Intangible asset impairment charges
 
 
 
 
 
 
 
 
(224.0
)
Globally managed research and development costs
 
 
 
 
 
 
 
 
(250.3
)
Corporate costs and special items
 
 
 
 
 
 
 
 
(683.1
)
Litigation settlements & other contingencies
 
 
 
 
 
 
 
 
49.5

Earnings from operations
 
 
 
 
 
 
 
 
$
905.6

 
North America
 
Europe
 
Rest of World
 
Corporate / Other
 
Consolidated
Year Ended December 31, 2017
 
 
 
 
 
 
 
 
 
Net sales
$
4,969.6

 
$
3,958.3

 
$
2,832.1

 
$
—

 
$
11,760.0

Other revenue
86.5

 
36.5

 
24.7

 
—

 
147.7

Intersegment revenue
74.6

 
112.4

 
379.2

 
(566.2
)
 
—

Total
$
5,130.7

 
$
4,107.2

 
$
3,236.0

 
$
(566.2
)
 
$
11,907.7

 
 
 
 
 
 
 
 
 
 
Segment profitability
$
2,497.1

 
$
1,082.8

 
$
572.7

 
$
—

 
$
4,152.6

 
 
 
 
 
 
 
 
 
 
Intangible asset amortization expense
 
 
 
 
 
 
 
 
(1,437.4
)
Intangible asset impairment charges
 
 
 
 
 
 
 
 
(80.8
)
Globally managed research and development costs
 
 
 
 
 
 
 
 
(356.4
)
Corporate costs and special items
 
 
 
 
 
 
 
 
(853.9
)
Litigation settlements & other contingencies
 
 
 
 
 
 
 
 
13.1

Earnings from operations
 
 
 
 
 
 
 
 
$
1,437.2

 
North America
 
Europe
 
Rest of World
 
Corporate / Other
 
Consolidated
Year Ended December 31, 2016
 
 
 
 
 
 
 
 
 
Net sales
$
5,629.5

 
$
2,953.8

 
$
2,383.8

 
$
—

 
$
10,967.1

Other revenue
88.4

 
12.6

 
8.8

 
—

 
109.8

Intersegment revenue
45.4

 
106.3

 
407.6

 
(559.3
)
 
—

Total
$
5,763.3

 
$
3,072.7

 
$
2,800.2

 
$
(559.3
)
 
$
11,076.9

 
 
 
 
 
 
 
 
 
 
Segment profitability
$
2,921.2

 
$
669.4

 
$
423.5

 
$
—

 
$
4,014.1

 
 
 
 
 
 
 
 
 
 
Intangible asset amortization expense
 
 
 
 
 
 
 
 
(1,195.3
)
Intangible asset impairment charges
 
 
 
 
 
 
 
 
(68.3
)
Globally managed research and development costs
 
 
 
 
 
 
 
 
(423.7
)
Corporate costs and special items
 
 
 
 
 
 
 
 
(955.1
)
Litigation settlements & other contingencies
 
 
 
 
 
 
 
 
(672.5
)
Earnings from operations
 
 
 
 
 
 
 
 
$
699.2
Schedule of Revenue by Major Customers by Reporting Segments
The following table represents the percentage of consolidated net sales to Mylan’s major customers during the years ended December 31, 2018, 2017, and 2016:
 
Percentage of Consolidated Net Sales
 
2018
 
2017
 
2016
McKesson Corporation
12
%
 
13
%
 
16
%
AmerisourceBergen Corporation
8
%
 
8
%
 
14
%
Cardinal Health, Inc.
8
%
 
10
%
 
11
%
Net Third Party Sales Classified Based on Geographic Location of Subsidiaries
Net sales by country are presented on the basis of geographic location of our subsidiaries:
 
Year Ended December 31,
(In millions)
2018
 
2017
 
2016
United States
$
3,865.2

 
$
4,683.7

 
$
5,385.6

India
1,164.8

 
1,082.6

 
985.8

The Netherlands (1)
132.2

 
117.5

 
88.3

Other countries (2)
6,106.5

 
5,876.2

 
4,507.4

 
$
11,268.7

 
$
11,760.0

 
$
10,967.1

____________
(1) 
Mylan N.V. has its corporate seat in the Netherlands.
(2) 
No other country’s net sales represents more than 10% of consolidated net sales for the years ended December 31, 2018, 2017 and 2016, respectively.